These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28455235)

  • 1. Computational prediction and analysis of deleterious cancer associated missense mutations in DYNC1H1.
    Sucularli C; Arslantas M
    Mol Cell Probes; 2017 Aug; 34():21-29. PubMed ID: 28455235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel dynein DYNC1H1 neck and motor domain mutations link distal spinal muscular atrophy and abnormal cortical development.
    Fiorillo C; Moro F; Yi J; Weil S; Brisca G; Astrea G; Severino M; Romano A; Battini R; Rossi A; Minetti C; Bruno C; Santorelli FM; Vallee R
    Hum Mutat; 2014 Mar; 35(3):298-302. PubMed ID: 24307404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects.
    Willemsen MH; Vissers LE; Willemsen MA; van Bon BW; Kroes T; de Ligt J; de Vries BB; Schoots J; Lugtenberg D; Hamel BC; van Bokhoven H; Brunner HG; Veltman JA; Kleefstra T
    J Med Genet; 2012 Mar; 49(3):179-83. PubMed ID: 22368300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy.
    Harms MB; Ori-McKenney KM; Scoto M; Tuck EP; Bell S; Ma D; Masi S; Allred P; Al-Lozi M; Reilly MM; Miller LJ; Jani-Acsadi A; Pestronk A; Shy ME; Muntoni F; Vallee RB; Baloh RH
    Neurology; 2012 May; 78(22):1714-20. PubMed ID: 22459677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome Sequencing Identifies De Novo DYNC1H1 Mutations Associated With Distal Spinal Muscular Atrophy and Malformations of Cortical Development.
    Chen Y; Xu Y; Li G; Li N; Yu T; Yao RE; Wang X; Shen Y; Wang J
    J Child Neurol; 2017 Mar; 32(4):379-386. PubMed ID: 28193117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical-phenotype continuum in DYNC1H1-related disorders-genomic profiling and proposal for a novel classification.
    Becker LL; Dafsari HS; Schallner J; Abdin D; Seifert M; Petit F; Smol T; Bok L; Rodan L; Krapels I; Spranger S; Weschke B; Johnson K; Straub V; Kaindl AM; Di Donato N; von der Hagen M; Cirak S
    J Hum Genet; 2020 Nov; 65(11):1003-1017. PubMed ID: 32788638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical spectrum of dyneinopathies.
    Peeters K; Bervoets S; Chamova T; Litvinenko I; De Vriendt E; Bichev S; Kancheva D; Mitev V; Kennerson M; Timmerman V; De Jonghe P; Tournev I; MacMillan J; Jordanova A
    Hum Mutat; 2015 Mar; 36(3):287-91. PubMed ID: 25512093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of DYNC1H1 mutations with intractable epilepsy.
    Matsumoto A; Kojima K; Miya F; Miyauchi A; Watanabe K; Iwamoto S; Kawai K; Kato M; Takahashi Y; Yamagata T
    Brain Dev; 2021 Sep; 43(8):857-862. PubMed ID: 34092403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological Hallmarks of Brain Malformations in Extreme Phenotypes Related to DYNC1H1 Mutations.
    Laquerriere A; Maillard C; Cavallin M; Chapon F; Marguet F; Molin A; Sigaudy S; Blouet M; Benoist G; Fernandez C; Poirier K; Chelly J; Thomas S; Bahi-Buisson N
    J Neuropathol Exp Neurol; 2017 Mar; 76(3):195-205. PubMed ID: 28395088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic dynein heavy chain: the servant of many masters.
    Schiavo G; Greensmith L; Hafezparast M; Fisher EM
    Trends Neurosci; 2013 Nov; 36(11):641-51. PubMed ID: 24035135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in DYNC1H1 gene causing spinal muscular atrophy - Lower extremity, dominant.
    Das J; Lilleker JB; Jabbal K; Ealing J
    Neurol Neurochir Pol; 2018 Mar; 52(2):293-297. PubMed ID: 29306600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1.
    Strickland AV; Schabhüttl M; Offenbacher H; Synofzik M; Hauser NS; Brunner-Krainz M; Gruber-Sedlmayr U; Moore SA; Windhager R; Bender B; Harms M; Klebe S; Young P; Kennerson M; Garcia AS; Gonzalez MA; Züchner S; Schule R; Shy ME; Auer-Grumbach M
    J Neurol; 2015 Sep; 262(9):2124-34. PubMed ID: 26100331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle and bone characteristics of a Chinese family with spinal muscular atrophy, lower extremity predominant 1 (SMALED1) caused by a novel missense DYNC1H1 mutation.
    Mei Y; Jiang Y; Zhang Z; Zhang H
    BMC Med Genomics; 2023 Mar; 16(1):47. PubMed ID: 36882741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DYNC1H1 variants associated with infant-onset epilepsy without neurodevelopmental disorders.
    Wu WC; Liang XY; Zhang DM; Jin L; Liu ZG; Zeng XL; Zhai QX; Liao WP; He N; Meng XH
    Seizure; 2024 Mar; 116():119-125. PubMed ID: 37903666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker.
    Bai J; Yang B; Shi R; Shao X; Yang Y; Wang F; Xiao J; Qu X; Liu Y; Zhang Y; Li Z
    Aging (Albany NY); 2020 Nov; 12(24):25101-25119. PubMed ID: 33221769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome Sequencing Identifies DYNC1H1 Variant Associated With Vertebral Abnormality and Spinal Muscular Atrophy With Lower Extremity Predominance.
    Punetha J; Monges S; Franchi ME; Hoffman EP; Cirak S; Tesi-Rocha C
    Pediatr Neurol; 2015 Feb; 52(2):239-44. PubMed ID: 25484024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of computational methods for predicting the effects of missense mutations in human cancers.
    Gnad F; Baucom A; Mukhyala K; Manning G; Zhang Z
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S7. PubMed ID: 23819521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conditional null allele of Dync1h1 enables targeted analyses of dynein roles in neuronal length sensing.
    Di Pizio A; Marvaldi L; Birling MC; Okladnikov N; Dupuis L; Fainzilber M; Rishal I
    J Cell Sci; 2023 Mar; 136(5):. PubMed ID: 36218033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prognosis Marker Dynein Cytoplasmic 1 Heavy Chain 1 Correlates with EMT and Immune Signature in Liver Hepatocellular Carcinoma by Bioinformatics and Experimental Analysis.
    Wang Y; Han J; Zhou H; Ai S; Wan D
    Dis Markers; 2022; 2022():6304859. PubMed ID: 35601740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing identifies a novel de novo mutation in DYNC1H1 in epileptic encephalopathies.
    Lin Z; Liu Z; Li X; Li F; Hu Y; Chen B; Wang Z; Liu Y
    Sci Rep; 2017 Mar; 7(1):258. PubMed ID: 28325891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.